Eiko Lifescience

  • Market Cap: Micro Cap
  • Industry: Specialty Chemicals
  • ISIN: INE666Q01016
  • NSEID:
  • BSEID: 540204
INR
47.03
-0.15 (-0.32%)
BSENSE

Sep 01, 03:30 PM

BSE+NSE Vol: 2.26 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'26
Mar'25
Mar'20
Mar'19
Mar'18
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
Share Capital
14.35
13.76
3.82
3.82
3.82
Share Warrants & Outstandings
Total Reserve
50.38
43.03
-0.87
1.10
1.74
Shareholder's Funds
68.78
56.79
2.95
4.92
5.56
Minority Interest
1.05
0.22
-1.83
-0.12
0.48
Long-Term Borrowings
3.06
2.01
1.61
0.00
0.00
Secured Loans
3.06
2.01
1.61
0.00
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
1.11
0.82
-1.63
-0.27
0.03
Other Long Term Liabilities
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.05
0.06
Total Non-Current Liabilities
4.17
2.83
-0.02
0.15
0.51
Current Liabilities
Trade Payables
12.56
3.31
3.85
1.40
2.29
Other Current Liabilities
0.88
2.03
5.46
0.00
0.00
Short Term Borrowings
1.67
0.76
0.00
0.00
0.00
Short Term Provisions
0.27
0.17
0.02
0.04
0.05
Total Current Liabilities
15.38
6.27
9.33
4.44
5.48
Total Liabilities
89.37
66.10
10.42
9.03
10.95
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
Gross Block
25.95
25.95
1.75
1.45
2.27
Less: Accumulated Depreciation
3.85
2.83
0.00
0.00
0.58
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
Net Block
22.10
23.12
1.75
1.45
1.68
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
Non Current Investments
15.29
7.15
0.10
1.72
3.17
Long Term Loans & Advances
4.57
2.95
2.09
0.05
0.04
Other Non Current Assets
0.00
0.00
1.71
0.00
0.00
Total Non-Current Assets
41.96
33.22
5.39
2.18
2.20
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
1.72
3.17
Inventories
3.97
5.77
3.21
2.31
3.10
Sundry Debtors
20.22
10.79
1.18
0.86
1.46
Cash and Bank
13.61
11.78
0.02
0.11
0.80
Other Current Assets
0.06
0.00
0.14
0.00
0.00
Short Term Loans and Advances
9.55
4.53
0.47
0.00
0.00
Total Current Assets
47.41
32.88
5.03
2.70
5.98
Net Current Assets (Including Current Investments)
32.03
26.61
-4.30
0.00
1.32
Total Current Assets Excluding Current Investments
47.41
32.88
5.03
0.97
5.98
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
Total Assets
89.37
66.10
10.42
9.03
10.95
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
Total Debt
4.73
2.76
1.61
0.00
0.00
Book Value per share (adjusted)
45.12
41.26
6.68452675111192
12.89
14.56
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2026 is 71.38% vs NA in Mar 2025

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2026 is -4.41% vs NA in Mar 2025

stock-summary

Investments

YoY Growth in year ended Mar 2026 is 113.85% vs NA in Mar 2025

stock-summary

Current Assets

YoY Growth in year ended Mar 2026 is 44.19% vs NA in Mar 2025

Compare Balance Sheet Results of Eiko Lifescience
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
14.35
0
14.35
0.00%
Share Warrants & Outstandings
Total Reserve
50.38
0
50.38
0.00%
Shareholder's Funds
68.78
0
68.78
0.00%
Minority Interest
1.05
0
1.05
0.00%
Long-Term Borrowings
3.06
0
3.06
0.00%
Secured Loans
3.06
0
3.06
0.00%
Unsecured Loans
0.00
0
0.00
0.00%
Deferred Tax Assets / Liabilities
1.11
0
1.11
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
4.17
0
4.17
0.00%
Current Liabilities
Trade Payables
12.56
0
12.56
0.00%
Other Current Liabilities
0.88
0
0.88
0.00%
Short Term Borrowings
1.67
0
1.67
0.00%
Short Term Provisions
0.27
0
0.27
0.00%
Total Current Liabilities
15.38
0
15.38
0.00%
Total Liabilities
89.37
0
89.37
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
25.95
0
25.95
0.00%
Less: Accumulated Depreciation
3.85
0
3.85
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
22.10
0
22.10
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
0.00
0
0.00
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
15.29
0
15.29
0.00%
Long Term Loans & Advances
4.57
0
4.57
0.00%
Other Non Current Assets
0.00
0
0.00
0.00%
Total Non-Current Assets
41.96
0
41.96
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
3.97
0
3.97
0.00%
Sundry Debtors
20.22
0
20.22
0.00%
Cash and Bank
13.61
0
13.61
0.00%
Other Current Assets
0.06
0
0.06
0.00%
Short Term Loans and Advances
9.55
0
9.55
0.00%
Total Current Assets
47.41
0
47.41
0.00%
Net Current Assets (Including Current Investments)
32.03
0
32.03
0.00%
Total Current Assets Excluding Current Investments
47.41
0
47.41
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
89.37
0
89.37
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
4.73
0
4.73
0.00%
Book Value per share (adjusted)
45.12
0
45.12
0.00%
Annual - Borrowings
Borrowings 4.73 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 71.38% vs NA in Mar 2025

Annual - Other Long Term Liabilities
Markets Mojo
No Other Long Term Liabilities in the last few periods
stock-summary

YoY Growth in year ended Mar 2026 is 0.00% vs NA in Mar 2025

Annual - Fixed Assets
Fixed Assets 22.10 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is -4.41% vs NA in Mar 2025

Annual - Investments
Investments 15.29 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 113.85% vs NA in Mar 2025

Annual - Current Assets
Current Assets 47.41 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 44.19% vs NA in Mar 2025